Skip to Content
Top

BY Scott Merville

MD Anderson’s Moon Shots Program has expanded its targets, adding some of the most intractable cancers to its campaign to more rapidly convert scientific discoveries into life-saving advances.

The innovative program’s transdisciplinary team-science approach and transformative professional platforms now pursue meaningful progress against B-cell lymphoma, glioblastoma (brain cancer), HPV associated cancers (caused by the human papilloma...

BY MD Anderson staff

It’s been a year since CVS Pharmacy, the nation’s second largest chain of drugstores, stopped selling tobacco, and the company claims the...

BY Bryan Tutt

A vaccine that delivers an antigen to dendritic cells, in turn activating killer T cells that can target specific cancers, is being investigated...

BY Sarah Bronson

Patients who undergo surgery are recovering faster and getting discharged sooner thanks to MD Anderson’s enhanced surgical recovery programs (ESRPs).

The ESRP approach includes skipping routine preoperative bowel preparation, using minimally invasive surgical techniques when possible, using goal-directed fluid therapy, minimizing the use of opioids in pain management, limiting the routine use of tubes and drains, and encouraging...

BY Clayton Boldt

For the first time, a new drug from the field of immuno-oncology has proven to extend survival for patients with advanced kidney cancer, a...

BY Laura Sussman

Rafael Pantoja had all but lost hope.

The thyroid cancer he had battled for 14 years was back and spreading.

Then, earlier this...

BY MD Anderson staff

A drug for pancreatic cancer that is also used to prevent rejection of organ transplants has been shown to delay progression of another form...

BY Scott Merville

A career-long fascination with discovering the ins and outs of T cells, our immune system’s tailor-made destroyers of infections and dysfunctional...